Literature DB >> 22004660

Genetic variants, immune function, and risk of pre-eclampsia among American Indians.

Lyle G Best1, Melanie Nadeau, Kylie Davis, Felicia Lamb, Shellee Bercier, Cindy M Anderson.   

Abstract

PROBLEM: To determine the prevalence in an American Indian population of genetic variants with putative effects on immune function and determine if they are associated with pre-eclampsia (PE). METHOD OF STUDY: In a study of 66 cases and 130 matched controls, six single nucleotide polymorphisms (SNP) with either previously demonstrated or postulated modulating effects on the immune system were genotyped. Allele frequencies and various genetic models were evaluated by conditional logistic regression in both univariate and multiply adjusted models.
RESULTS: Although most genetic variants lacked evidence of association with PE, the minor allele of the CRP related, rs1205 SNP in a dominant model with adjustment for age at delivery, nulliparity, and body mass index, exhibited an odds ratio of 0.259 (95% CI of 0.08-0.81, P=0.020) in relation to severe PE (48 cases). The allelic prevalence of this variant was 46.1% in this population.
CONCLUSION: Of the six SNPs related to immune function in this study, a functional variant in the 3'UTR of the CRP gene was shown to be associated with severe PE in an American Indian population.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004660      PMCID: PMC3253256          DOI: 10.1111/j.1600-0897.2011.01076.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  47 in total

1.  Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population.

Authors:  R Arngrimsson; S Björnsson; R T Geirsson; H Björnsson; J J Walker; G Snaedal
Journal:  Br J Obstet Gynaecol       Date:  1990-09

2.  Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study.

Authors: 
Journal:  Am J Hum Genet       Date:  2005-05-11       Impact factor: 11.025

Review 3.  Searching for genetic clues to the causes of pre-eclampsia.

Authors:  Sally Chappell; Linda Morgan
Journal:  Clin Sci (Lond)       Date:  2006-04       Impact factor: 6.124

4.  Association study between C-reactive protein genes and ischemic stroke in Japanese subjects.

Authors:  Akihiko Morita; Tomohiro Nakayama; Masayoshi Soma
Journal:  Am J Hypertens       Date:  2006-06       Impact factor: 2.689

5.  Genetic variants, endothelial function, and risk of preeclampsia among American Indians.

Authors:  Lyle G Best; Melanie Nadeau; Shellee Bercier; Sara Dauphinais; Jacob Davis; Kylie Davis; Shyleen Poitra; Cindy M Anderson
Journal:  Hypertens Pregnancy       Date:  2010-12-21       Impact factor: 2.108

6.  Immunoregulatory gene polymorphisms in women with preeclampsia.

Authors:  Karen P T Pendeloski; Nelson Sass; Maria R Torloni; Rosiane Mattar; Antonio F Moron; Camila S Franchim; Silvia Daher
Journal:  Hypertens Res       Date:  2010-12-16       Impact factor: 3.872

7.  Association of common CRP gene variants with CRP levels and cardiovascular events.

Authors:  D T Miller; R Y L Zee; J Suk Danik; P Kozlowski; D I Chasman; R Lazarus; N R Cook; P M Ridker; D J Kwiatkowski
Journal:  Ann Hum Genet       Date:  2005-11       Impact factor: 1.670

8.  Cytokine gene polymorphisms in preeclampsia and eclampsia.

Authors:  Telmo H Barbosa de Lima; Nelson Sass; Rosiane Mattar; Antonio F Moron; Maria R Torloni; Camila S Franchim; Silvia Daher
Journal:  Hypertens Res       Date:  2009-05-01       Impact factor: 3.872

9.  Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults.

Authors:  E Komurcu-Bayrak; N Erginel-Unaltuna; A Onat; B Ozsait; C Eklund; M Hurme; N Mononen; R Laaksonen; G Hergenc; T Lehtimäki
Journal:  Atherosclerosis       Date:  2009-04-05       Impact factor: 5.162

10.  Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study.

Authors:  Mika Kivimäki; Debbie A Lawlor; George Davey Smith; Meena Kumari; Ann Donald; Annie Britton; Juan P Casas; Tina Shah; Eric Brunner; Nicholas J Timpson; Julian P J Halcox; Michelle A Miller; Steve E Humphries; John Deanfield; Michael G Marmot; Aroon D Hingorani
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

View more
  5 in total

1.  Pre-eclampsia in American Indians/Alaska Natives and Whites: The Significance of Body Mass Index.

Authors:  Anna Zamora-Kapoor; Lonnie A Nelson; Dedra S Buchwald; Leslie R Walker; Beth A Mueller
Journal:  Matern Child Health J       Date:  2016-11

2.  Analysis of Complement C3 Gene Reveals Susceptibility to Severe Preeclampsia.

Authors:  A Inkeri Lokki; Tea Kaartokallio; Ville Holmberg; Päivi Onkamo; Lotta L E Koskinen; Päivi Saavalainen; Seppo Heinonen; Eero Kajantie; Juha Kere; Katja Kivinen; Anneli Pouta; Pia M Villa; Leena Hiltunen; Hannele Laivuori; Seppo Meri
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

3.  Unactivated leukocyte expression of C-reactive protein is minimal and not dependent on rs1205 genotype.

Authors:  L G Best; C Azure; K Martell; K S Tsosie; B Voels
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

4.  Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population.

Authors:  Lyle G Best; Richa Saxena; Cindy M Anderson; Michael R Barnes; Hakon Hakonarson; Gilbert Falcon; Candelaria Martin; Berta Almoguera Castillo; Ananth Karumanchi; Kylie Keplin; Nichole Pearson; Felicia Lamb; Shellee Bercier; Brendan J Keating
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

5.  IBC CARe microarray allelic population prevalences in an American Indian population.

Authors:  Lyle G Best; Cindy M Anderson; Richa Saxena; Berta Almoguera; Hareesh Chandrupatla; Candelaria Martin; Gilbert Falcon; Kylie Keplin; Nichole Pearson; Brendan J Keating
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.